Author/Creator: Sun, Hefen - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Sun, Hefen

1. A pharmacophore‐based classification better predicts the outcomes of HER2‐negative breast cancer patients receiving the anthracycline‐ and/or taxane‐based neoadjuvant chemotherapy. (2nd June 2021)

Authors:: Li, Xuan; Sun, Hefen; Liu, Qiqi; Liu, Yang; Hou, Yifeng; Jin, Wei
Journal:: Cancer medicine
Issue:: Volume 10:Number 13(2021)
Page Start:: 4658
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. HTR1A Inhibits the Progression of Triple‐Negative Breast Cancer via TGF‐β Canonical and Noncanonical Pathways. Issue 12 (24th February 2022)

Authors:: Liu, Qiqi; Sun, Hefen; Liu, Yang; Li, Xuan; Xu, Baojin; Li, Liangdong; Jin, Wei
Journal:: Advanced science
Issue:: Volume 9:Issue 12(2022)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Targeted delivery of CD44s-siRNA by ScFv overcomes de novo resistance to cetuximab in triple negative breast cancer. (July 2018)

Authors:: Fu, Wenyan; Sun, Hefen; Zhao, Yang; Chen, Mengting; Yang, Lipeng; Yang, Xueli; Jin, Wei
Journal:: Molecular immunology
Issue:: Volume 99(2018:Jul.)
Page Start:: 124
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway. Issue 4 (26th February 2018)

Authors:: Hou, Helei; Ge, Chao; Sun, Hefen; Li, Hong; Li, Jinjun; Tian, Hua
Journal:: Cancer science
Issue:: Volume 109:Issue 4(2018)
Page Start:: 1088
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗